Hydrocephalus Research Unit, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg 413 45, Sweden.
J Neurol Neurosurg Psychiatry. 2013 May;84(5):562-8. doi: 10.1136/jnnp-2012-303314. Epub 2012 Dec 18.
The objective was to determine the sensitivity, specificity, and positive and negative predictive values of the CSF Tap Test (CSF TT) and resistance to CSF outflow (Rout) for the outcome of shunting in a sample of patients with idiopathic normal pressure hydrocephalus (iNPH).
115 patients were included in this European multicentre study. Diagnosis was based on clinical symptoms and signs, and MRI changes. All patients were treated with programmable ventriculoperitoneal shunts and re-examined 12 months after surgery. Outcomes were measures with a newly developed iNPH Scale and the modified Rankin Scale (mRS). Before surgery, a CSF TT and measurement of Rout was performed, with the results blinded to all caregivers. The 12 month outcome was correlated with Rout and the result of the CSF TT.
Rout and the results of the CSF TT showed no correlation with outcome measured by either domain, or with total iNPH score or mRS score. Only an increase in the gait task (10 m of walking at free speed) of the CSF TT correlated significantly (r=0.22, p=0.02) with improvement in iNPH score. The positive predictive value of both tests was >90% and the negative predictive value <20%. Rout >12 had an overall accuracy of 65% and the CSF TT 53%. Combining both tests did not improve their predictive power. No correlation was found between Rout and the results of the CSF TT.
Rout and the results of the CSF TT did not correlate with outcome after 12 months. Rout and CSF TT can be used for selecting patients for shunt surgery but not for excluding patients from treatment.
The study has been registered at clinicaltrials.gov, identifier NCT00874198.
本研究旨在确定脑脊液(CSF) tapp 测试(CSF TT)和 CSF 流出阻力(Rout)对特发性正常压力脑积水(iNPH)患者分流术结果的敏感性、特异性、阳性和阴性预测值。
本研究纳入了 115 名患者,这些患者来自欧洲多中心研究。该研究采用临床症状和体征以及 MRI 改变来进行诊断。所有患者均接受程控脑室-腹腔分流术治疗,并在术后 12 个月时进行复查。采用新开发的 iNPH 量表和改良 Rankin 量表(mRS)对结果进行评估。在手术前,对 Rout 进行了 CSF TT 测试和测量,结果对所有护理人员均保密。将 12 个月的结果与 Rout 和 CSF TT 测试的结果进行了相关性分析。
Rout 和 CSF TT 测试的结果与通过任何一个域评估的结果、总 iNPH 评分或 mRS 评分均无相关性。仅 CSF TT 测试中步态任务(自由速度行走 10 米)的增加与 iNPH 评分的改善显著相关(r=0.22,p=0.02)。两种测试的阳性预测值均>90%,阴性预测值均<20%。Rout>12 的总准确性为 65%,CSF TT 为 53%。联合两种测试并不能提高其预测能力。未发现 Rout 和 CSF TT 测试的结果之间存在相关性。
Rout 和 CSF TT 测试的结果与 12 个月后的结果无关。Rout 和 CSF TT 测试可用于选择接受分流手术的患者,但不能用于排除治疗患者。
该研究已在 clinicaltrials.gov 上注册,标识符为 NCT00874198。